Actualités de PARIS

11.11.2014 – 13:51
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb-Sponsored Partnering for Cure(TM) Programme Announces New Winning Projects Designed to Investigate Novel Ways to Cure Viral Diseases
Paris (ots/PRNewswire) - The Partnering for Cure faculty of experts today announced the four recipients of awards for research proposals that will help to provide insights into the pathophysiology of viral diseases and the potential development of cure strategies in HIV, hepatitis B (HBV) and hepatitis C (HCV). As ...
plus
08.10.2014 – 10:12
TagCommander
TagCommander Raises EUR6.5 Million Series B Funding
Paris (ots/PRNewswire) - Round of investment will help Paris-based enterprise tag management pioneer accelerate its European expansion. TagCommander, a European pioneer and leader in the growing market for enterprise tag management systems, has today announced a EUR6.5 million Series B investment led by Hi Inov - Dentressangle Initiatives, with participation from XAnge Private Equity, an investor in the company since ...
plus
17.09.2014 – 15:38
Bloomberg Philanthropies
Five Cities Selected as Winners in Bloomberg Philanthropies 2014 Mayors Challenge
Paris (ots/PRNewswire) - Grand Prize Winner Barcelona Aims to Create Digital and Community 'Trust Network' for Each of its At-Risk Elderly Residents Athens, Greece; Kirklees in Yorkshire, UK; Stockholm, Sweden; and Warsaw, Poland Also Win Funds for Innovative Solutions to Pressing Urban Challenges Bloomberg Philanthropies today announced the winners in its 2014 Mayors ...
plus
04.09.2014 – 09:01
Exelgyn
25th Anniversary of Women's Access to Medical Abortion with Mifegyne®
Paris (ots/PRNewswire) - The approval of Mifegyne(R) was the successful outcome of a long struggle. Its launch in France in 1989, soon followed by other European countries, was the final point of several decades of harsh debate, giving women more autonomy and the choice to medically terminate an unwanted pregnancy. Mifegyne(R) has changed the way abortion was perceived ...
plus
03.09.2014 – 11:38
Renault-Nissan Alliance
Renault-Nissan Alliance & Orange Expand Electric Vehicle Partnership
Paris (ots/PRNewswire) - - Renault-Nissan to supply 200 electric vehicles to Orange in France by 2015, mostly for car-sharing purposes - Fleet will comprise Renault ZOE, Renault Kangoo Z.E., Nissan LEAF and Nissan e-NV200 - Agreement expected to help contribute to Orange's commitment to reduce its CO2 footprint by 20% by 2020 The Renault-Nissan Alliance has signed an ...
plus
21.07.2014 – 13:26
Artprice.com
More Info on Listing of Artmarket.com (Subsidiary of Artprice Inc. USA) From the Minutes of the Artprice AGM and Its Document Presenting Future Events
Paris (ots/PRNewswire) - Following publication of the minutes of Artprice's AGM on 27 June 2014 together with a presentation of Artprice's "Future Outlook" (link to the online pdf file at the bottom of this page) that was discussed during the meeting, there had been substantial demand from shareholders and the ...
plus
02.07.2014 – 14:01
Renault-Nissan Alliance
Renault-Nissan Alliance Posts Record EUR2.9B Synergies in 2013 Ahead of Launch of First Common Module Family Vehicles
Paris And Yokohama, Japan (ots/PRNewswire) - - Purchasing, powertrain and vehicle engineering areas remain the biggest contributors to synergies - "Non-traditional" business functions, such as sales and marketing, increase contributions - Moving forward, synergies are expected to accelerate with "convergence" in ...
plus
30.06.2014 – 10:03
Bristol-Myers Squibb GmbH & Co. KGaA
SHE Day: The Strong, HIV Positive, Empowered Women (SHE) Faculty and Bristol-Myers Squibb Celebrated Four Years of SHE, a First-of-Its Kind Programme Addressing the Specific Challenges Faced by Women Living with HIV in Europe
Paris (ots/PRNewswire) - - The SHE network continues to expand across Europe to empower and educate women living with HIV and their health care providers - More than 60 SHE units, multidisciplinary teams based in HIV clinics and dedicated to women with HIV, have been implemented in 18 countries 'SHE' (Strong, HIV ...
plus
17.06.2014 – 12:51
Label 5
Label 5 Kicks Off an Instagram Video Contest: 5" City
Paris (ots/PRNewswire) - Leading Scotch Whisky Brand LABEL 5, is launching in mid-June an amazing competition through its Facebook pages, the 5" City contest, which invites its worldwide fans to take a 5-second Instagram video of their favourite city, to get a chance to win a round-the-world trip for 2! To view the Multimedia News Release, please click: ...
plus
16.06.2014 – 18:06
Sanofi Diabetes
TEENs Study Shows Achieving Target Blood Sugar Levels is Associated with Better Quality of Life for Young People with Type 1 Diabetes
Paris (ots/PRNewswire) - - Findings set foundation to drive recommendations for enhancing care - Sanofi announced today the first results of the TEENs Registry Study, the largest contemporary real-world study of the care of nearly 6,000 young people with type 1 diabetes, ages 8 to 25. The findings not only ...
plus
14.06.2014 – 19:34
Sanofi Diabetes
Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering Than Liraglutide When Both Were Added to Insulin Glargine
Paris (ots/PRNewswire) - Sanofi announced today that Lyxumia(R) (lixisenatide) met the primary endpoint in an 8-week head-to-head pharmacodynamic study versus liraglutide, showing a significantly more pronounced post-prandial (after-meal) glucose (blood sugar) lowering effect after a test-meal than liraglutide when ...
plus
14.06.2014 – 19:07
Sanofi Diabetes
Sanofi Announces Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) in Japanese People with Uncontrolled Diabetes
Paris (ots/PRNewswire) - - In EDITION JP I and II, investigational Toujeo(R)demonstrated similar blood sugar control with fewer night-time low blood sugar events over 6-month study period, vs. Lantus(R)- Sanofi announced today full results from EDITION JP I and EDITION JP II that showed Toujeo(R) (insulin glargine ...
plus
10.06.2014 – 20:17
Sanofi Diabetes
Sanofi to Present New Clinical Data at American Diabetes Association 74th Scientific Sessions
Paris, France (ots/PRNewswire) - - New results for Toujeo(R)(insulin glargine [rDNA origin] injection, 300 U/mL; "U300") from EDITION I/II/III meta-analysis, EDITION III, IV, JP 1 and JP 2 studies are among over 65 abstracts to be presented - Sanofi announced today that new data on U300, Lyxumia(R) (lixisenatide) ...
plus
15.05.2014 – 23:32
Vocalcom
New Frontier Group and Vocalcom Announce Global Partnership for Distribution of Advanced Cloud Based Customer Interaction Solutions
Paris (ots/PRNewswire) - Vocalcom, leading provider of multi-channel contact center software and New Frontier Group, a leading IT solution company in CEE & beyond, today announced a partnership aiming to bring the Vocalcom's Effortless Contact Center(TM) solution to Central and Eastern Europe (CEE) and Commonwealth ...
plus
08.04.2014 – 11:10
Bristol-Myers Squibb GmbH & Co. KGaA
European Researchers Invited to Submit Study Proposals for Bristol-Myers Squibb's Partnering for Cure(TM) Virology Research Programme
Paris (ots/PRNewswire) - Partnering for Cure is Bristol-Myers Squibb's flagship, Pan-European scientific initiative supporting breakthrough research and facilitating greater collaboration and knowledge-sharing with the virology community In advance of this year's International Liver CongressTM 2014 in London, ...
plus
18.03.2014 – 18:10
Eurazeo
Eurazeo Invests EUR285 Million in Desigual
Paris (ots/PRNewswire) - Eurazeo announces its partnership with Desigual to accompany the growth of the brand. Eurazeo will subscribe to a EUR285 million capital increase and receive 10% of the share capital of the group owned by its founder, Thomas Meyer. This agreement grants Eurazeo governance and investment protection rights, reflecting the true partnership forged between the parties. To view the Multimedia News ...
plus
17.03.2014 – 10:45
Nestle Waters
World Water Day 2014 at Nestlé Waters: "Together for Water"
Paris (ots/PRNewswire) - Nestlé Waters supports World Water Day around the world for the fifth year running through a cooperative approach : more than 500 employees in around 30 countries are welcoming 15 000 children, as well as fellow collaborators and local communities, to fun, interactive events focused on increasing awareness about water conservation and healthy hydration. To view the Multimedia News Release, please ...
plus
04.03.2014 – 19:40
ETAM
#ETAM Live Show: The Sexiest, Most Connected Catwalk Show of the Year
Paris (ots/PRNewswire) - A spectacular stage, 80 breathtaking models, 5 tableaux and 6 live artists staged a collection in which the French brand's virtuosity in terms of corsetry was fully expressed. The event was at the same time hyped and universal thanks to some ultra-digitalised communication apparatus. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/65024-live-show-etam-catwalk ON THE ...
plus
25.02.2014 – 11:01
ETAM
7th Edition of Etam Live Show
Paris (ots/PRNewswire) - Today, 25th February 2014, Etam opens Fashion Week with the sexiest show of the year. A concert with 6 international performers, 80 breath-taking models, 5 themes, black, white and colour, cobweb-like lace embroidered with beads, feathers, rhinestones and an exclusive and highly inspired collection signed by the brand's muse, Natalia Vodianova. To view the Multimedia News Release, please click: ...
plus
24.02.2014 – 09:02
Groupe La Martiniquaise
POLIAKOV, the First Vodka into Space
Paris (ots/PRNewswire) - How far will the "K Degree" experiment go? POLIAKOV, the world's most Extreme Vodka, has launched a one-of-a-kind experiment in a quest to reach the ultimate level of cold: the K Degree, the most freezing temperature one may find in the universe, at -273degree(s)C. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/64998-a-la-conquete-de-lespace-avec-poliakov The "K ...
plus
11.02.2014 – 08:02
Prover Technology and IKOS
Prover Technology and IKOS Consulting Join Forces to Meet Customer Demand for Automated Rail Control Development
Stockholm And Paris (ots/PRNewswire) - Prover Technology, a world leader in software technology for Automated Development of Rail Control Software, and IKOS, a leading consulting firm specialized in railway engineering, today announced that they will join forces to better serve customers who seek to introduce ...
plus
07.02.2014 – 10:02
Renault-Nissan Alliance
Renault-Nissan Alliance Posts Record Sales in 2013
Paris (ots/PRNewswire) - - Sales rise to 8.3 million units amid record demand in China and the United States - Alliance sales, including AVTOVAZ, account for one in ten cars sold worldwide - Zero-emission sales up more than 50% from 2012 The Renault-Nissan Alliance sold a record 8,266,098 vehicles in 2013, propelled by record sales in the car group's two largest markets, China and the United States. Renault-Nissan's 2013 ...
plus
06.02.2014 – 09:53
Nestlé Waters
Why Should Children be Kept Sufficiently Hydrated While Going to School?
Paris (ots/PRNewswire) - Everybody needs to drink water to keep sufficiently hydrated to deal with their day either at work for adults or for children at school. It is important to get into the habit of drinking a glass of water several times during the day and to teach children the healthy habit to drink water during their breaks at school. To view the Multimedia News ...
plus
31.01.2014 – 08:02
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb-Sponsored Partnering for Cure(TM) Program Names Three European Award Winners for Research Projects Focused on Cure in Viral Diseases
Paris (ots/PRNewswire) - First-ever, Europe-wide scientific initiative designed to accelerate virology clinical research & transform clinical outcomes for patients Three European virology researchers were awarded research grants this week based on their proposed research projects to investigate novel ways to cure ...
plus
05.12.2013 – 09:47
Sanofi Diabetes
New Data Support Flexibility in Timing of Administration for Sanofi's Lyxumia®
Paris (ots/PRNewswire) - - Similar glucose lowering effect when once-daily Lyxumia is administered before breakfast or the main meal - Sanofi announced today the results of a 24-week Phase IIIb clinical study showing that Lyxumia(R) (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered either before breakfast or ...
plus
04.12.2013 – 13:06
UBM Canon
More Extensive than Ever, Pharmapack Europe 2014 is Focused on Innovation so as to Meet the Expectations of the Healthcare Community
Paris (ots/PRNewswire) - The thirteenth edition of the Pharmapack Europe event will take place on 12-13 February 2014 at Paris Expo, Porte de Versailles. More than 3,000 visitors and 330 exhibitors from over 70 countries will gather in the new exhibition hall to review the latest innovations and trends in packaging ...
plus
08.11.2013 – 09:02
Bristol-Myers Squibb GmbH & Co. KGaA
YERVOY®(ipilimumab) Receives Marketing Authorisation for First-Line Treatment of Adult Patients with Advanced Melanoma in Europe
Paris, France (ots/PRNewswire) - Yervoy, an innovative immuno-oncology therapy that has demonstrated durable long-term survival in some patients,[1],[2] is now approved for use in previously-untreated patients Bristol-Myers Squibb today announced that the European Commission (EC) has approved YERVOY(R) (ipilimumab) ...
plus
18.10.2013 – 19:12
Label 5
Dive Into a Blue World : Launch of LABEL 5 18 YO Extra Rare
Paris (ots/PRNewswire) - LABEL 5 is adding a new expression in its brand family: LABEL 5 18 yo Extra Rare. Unveiled at TFWA Cannes next October, LABEL 5 Extra Rare respects the traditional Scotch Whisky codes whilst moving away the presentation to a contemporary blue style. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/63476-launch-of-label-5-18-YO-extra-rare LABEL 5 Extra Rare meets the ...
plus
02.10.2013 – 12:25
G.H.MUMM
G.H.MUMM Reveals its Latest Sabre Collaboration with Acclaimed Designer Ross Lovegrove
Paris (ots/PRNewswire) - G.H.MUMM House of Champagne unveiled its latest creation - The G.H.MUMM Sabre by Ross Lovegrove - an exceptional contemporary interpretation of one of the great rituals of Champagne by internationally acclaimed Designer Ross Lovegrove. To view the Multimedia News Release, please click: ...
plus
26.09.2013 – 07:02
Sanofi Diabetes
Sanofi Announces the CE Mark for JuniorSTAR®, a New Half-Unit Insulin Reusable Pen for People with Type 1 Diabetes
Paris (ots/PRNewswire) - Sanofi announced today at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, the CE Mark of JuniorSTAR(R), a new halfunit insulin reusable pen that can be used with Lantus(R) (insulin glargine), Apidra(R) (insulin glulisine) or Insuman(R) ...
plus

Précédent123456789Suivant